Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Open Access Highly Access Email this article to a friend

Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours

Jill E Kucab, Cathy Lee, Ching-Shih Chen, Jiuxiang Zhu, C Blake Gilks, Maggie Cheang, David Huntsman, Erika Yorida, Joanne Emerman, Michael Pollak and Sandra E Dunn*

Breast Cancer Research 2005, 7:R796-R807 doi:10.1186/bcr1294

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.